代表论文-江苏省肿瘤生物治疗研究所

代表论文

发布时间:2022年05月24日

浏览次数:

1. Hui Qiu, Zhiying Shao, Xin Wen,Longzhen Zhang*. New insights of extrachromosomal DNA in tumorigenesis and therapeutic resistance of cancer.American Journal of Cancer Research. 2020,10(12):4056-4065.

2. Hao Cui, Hongjian Shan, Michael Zhe Miao, Zhiguo Jiang, Yuanyuan Meng, Ran Chen,Longzhen Zhang*, Yong Liu*. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.Scientific Reports. 2020,10(1):4271.

3. Nianli Liu, Jiayin Ji, Hui Qiu, Zhiying Shao, Xin Wen, Aoxing Chen, Senbang Yao, Xingying Zhang, Hong Yao*,Longzhen Zhang*. Improving Radio-chemotherapy Efficacy of Prostate Cancer by Co-deliverying Docetaxel and Dbait with Biodegradable Nanoparticles.Artificial Cells Nanomedicine and Biotechnology. 2020,48(1):305-314.

4. Nianli Liu, Zhiyuan Wu, Aoxing Chen, Yuqi Wang, Dafei Cai, Junnian Zheng*, Yong Liu*,Longzhen Zhang*. SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26.Cell Death & Disease. 2019,10(9):667.

5. Nianli Liu, Zhiyuan Wu, Aoxing Chen, Dafei Chai, Liantao Li,Longzhen Zhang*, Junnian Zheng*.ISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cells.Journal of Cellular and Molecular Medicine. 2019,23(5):3520-3529.

6. Wenyan Zhang, Rui Duan, Jian Zhang, William KC Cheung, Xiaoge Gao, Raymond Zhang, Qing Zhang, Mengxue Zhang, Gang Wang, Qian Zhang, Pengjin Mei, Honglin Chen, Hsiangfu Kung, Marie C Lin, Zan Shen, Junnian Zheng,Longzhen Zhang*, Hong Yao*.H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.British Journal of Cancer. 2018,118(4):522-533.

7. Hongmei Liu, Yifan Cai, Yafei Zhang, Yandong Xie, Hui Qiu, Lei Hua, Xuejiao Liu, Yuling Li, Jun Lu,Longzhen Zhang*, Rutong Yu*. Development of a Hypoxic Radiosensitizer-Prodrug Liposome Delivery DNA Repair Inhibitor Dbait Combination with Radiotherapy for Glioma Therapy.Advanced Healthcare Materials. 2017 Jun;6(12).

8. Hui Qiu, Yuanzeng Min, Zach Rodgers,Longzhen Zhang*, Andrew Z. Wang*. Nanomedicine approaches to improve cancer immunotherapy.WIREs Nanomedicine & Nanobiotechnology. 2017 Sep;9(5).

9. Xinjun Zhang, Nianli Liu, Zhiying Shao, Hui Qiu, Hong Yao, Jiayin Ji, Jianshe Wang, Wenchao Lu, Ronald C. Chen*,Longzhen Zhang*. Folate-targeted nanoparticle delivery of androgen receptor shRNA enhances the sensitivity of hormone-independent prostate cancer to radiotherapy.Nanomedicine:NBM. 2017,13(4):1309-1321.

10. Hong Yao, Hui Qiu, Zhiying Shao, Gang Wang, Jianshe Wang, Yuanhu Yao, Yong Xin, Min Zhou, Andrew Z. Wang*,Longzhen Zhang*. Nanoparticle formulation of small DNA molecules, Dbait, improves the sensitivity of hormone-independent prostate cancer to radiotherapy.Nanomedicine:NBM.2016,12(8):2261-2271.

11. Zhiying Shao, Shalini Chaudhri, Meng Guo,Longzhen Zhang*, Daniel Rea*. Neoadjuvant chemotherapy in triple negative breast cancer: an observational study.Oncology Research. 2016,23(6):291-302.

12. Yuanzeng Min, Kyle C. Roche, Shaomin Tian, Michael J. Eblan, Karen P.McKinnon, Joseph M. Caster, Shengjie Chai, Laura E. Herring,Longzhen Zhang, Tian Zhang, Joseph M. DeSimone, Joel E. Tepper, Benjamin G. Vincent, Jonathan S. Serody, Andrew Z. Wang. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nature Nanotechnology. 2017,12(9):877-882.